Addressing translational barriers in intra-articular drug delivery for cartilage regeneration.
Despite growing interest in regenerative therapies for osteoarthritis (OA), clinical translation remains limited by biological and biophysical barriers that restrict target engagement within human cartilage. The recent identification of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) inhibition as a strategy for restor...